Additional Amount Of Debt Facility that Can be availed

No definition available.

Name:	bdsi_DebtInstrumentAdditionalFacilityThatCanBeObtained
Namespace Prefix:	bdsi_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Debt Instrument, Interest Only Payment Term

+ References

No definition available.

+ Details

Name:	bdsi_DebtInstrumentInterestOnlyPaymentTerm
Namespace Prefix:	bdsi_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Variable Rate, Floor

+ References

No definition available.

+ Details

Name:	bdsi_VariableRateFloor
Namespace Prefix:	bdsi_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	instant

- Definition

Percentage points added to the reference rate to compute the variable rate on the debt instrument.

+ References

No definition available.

+ Details

Name:	us-gaap_DebtInstrumentBasisSpreadOnVariableRate1
Namespace Prefix:	us-gaap_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_DebtInstrumentLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.

+ References

No definition available.

+ Details

Name:	us-gaap_DebtInstrumentTerm
Namespace Prefix:	us-gaap_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19(b),22(b))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

+ Details

Name:	us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Details

Name:	us-gaap_LongtermDebtTypeAxis=bdsi_BioPharmaCreditPlcMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Notes Payable - Additional Information (Detail) - Bio Pharma Credit Plc - USD ($)		6 Months Ended
	Apr. 01, 2021	Jun. 30, 2021	May 23, 2019
Debt Instrument [Line Items]
Secured credit term loan			$ 60,000,000.0
Additional facility funds that can be obtained			$ 20,000,000.0
Interest only, payment term		36 months
London Interbank Offered Rate (LIBOR)
Debt Instrument [Line Items]
Debt instrument, term		72 months
Basis spread on variable rate	0.20%	7.50%
Variable rate floor		2.00%